Methodology phase II clinical trial in cancer.
D000970:Antineoplastic Agents / Q000627:therapeutic use* / Q000633:toxicity; D004341:Drug Evaluation / Q000379:methods*; D004992:Ethics, Medical; D006801:Humans; D007564:Japan; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D011379:Prognosis; D012075:Remission, Spontaneous; D013997:Time Factors
D000970:Antineoplastic Agents